ICP DAS-BMP Presents Groundbreaking Medical TPU Innovations at COMPAMED 2026

ICP DAS-BMP Showcases Innovations at COMPAMED 2026



Introduction
ICP DAS-BMP, a prominent Taiwanese manufacturer of medical-grade thermoplastic polyurethane (TPU), will be making waves at the upcoming COMPAMED 2026, scheduled from November 16 to 19 at Messe Düsseldorf, Germany. The event will provide a significant platform for the company to showcase its diverse TPU product line, including exciting new developments through its participation in the newly formed Taiwan TPU Alliance.

Innovative TPU Products
At the forefront of ICP DAS-BMP's exhibition will be two noteworthy TPU innovations: the Low-Migration Series and the Low-Friction Series. These products aim to enhance the safety and effectiveness of medical devices.
  • - Low-Migration Arothane™ ARP-B20 TPU: Designed for implantation for up to 90 days, this new material complies with ISO 10993 standards. Its formulation effectively reduces additive migration to the surface of medical devices, ensuring long-term stability crucial for medical applications.
  • - Low-Friction Series: This series boasts a smooth surface inherent to TPU, removing the need for additional coatings or post-processing. Its design is particularly beneficial for handling invasive catheters with guidewires, as it promotes comfort and control, while being free from PFAS and plasticizers.

In addition to these innovations, the company will present the ARP, ALP, and ALC series, which are designed for limited, prolonged, and long-term contact durations in accordance with ISO 10993-1 guidelines. For medical devices requiring radiopaque properties, the ARP/ALP/ALC-B20/B40 series incorporates barium sulfate, while the ARP-W/WG series utilizes tungsten to enhance visibility during usage.

Taiwan TPU Alliance
Joining ICP DAS-BMP at COMPAMED 2026 is the Taiwan TPU Alliance, an initiative founded by Towards Buddha Co., Ltd., a manufacturer specializing in TPU tubing. This alliance is a collaborative effort that unites various industry partners, including INTYPE ENTERPRISE CO., LTD. for extrusion machinery, Chi Feng Co., Ltd. who focuses on injection molding components, A-MAX TECHNOLOGY CO., LTD. for auxiliary rubber and plastics equipment, and ANEST IWATA SPARMAX Co., Ltd. supplying air compressors and vacuum pumps.
Through this alliance, expertise is shared across the TPU and medical device manufacturing landscape, promoting better collaboration from the sourcing of medical-grade TPU materials to advanced manufacturing processes.

Company Background
ICP DAS-BMP prides itself as a leading manufacturer and supplier in the TPU domain, holding ISO 13485 certification, which emphasizes its commitment to quality management in the medical field. Drawing on over three decades of experience in industrial automation from its parent organization, ICP DAS, the company adopts smart factory strategies to enhance product quality and efficiency, ensuring timely delivery and customer satisfaction.

Conclusion
As leading innovations continue to emerge in medical technologies, the advancements presented by ICP DAS-BMP at COMPAMED 2026 underscore the significance of high-quality medical-grade materials. The collaborative efforts within the Taiwan TPU Alliance further highlight the industry’s commitment to innovation, safety, and technological advancement. For those interested in these developments, further information is available on ICP DAS-BMP's website.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.